The current financial score of Beyondspring Inc is 6.85. Its financial status is robust, and its operating efficiency is low.
The current valuation score of Beyondspring Inc is 8.26. Its current P/E ratio is -3.98, which is -76.10% below the recent high of -0.95 and -4029.45% above the recent low of -164.34.
No earnings forecast score is currently available for Beyondspring Inc. The Biotechnology & Medical Research industry's average is 8.12.
The current price momentum score of Beyondspring Inc is 6.65. Currently, the stock price is trading between the resistance level at 0.84 and the support level at 0.61, making it suitable for range-bound swing trading.
The current institutional shareholding score of Beyondspring Inc is 3.00. The latest institutional shareholding proportion is 14.61%, representing a quarter-over-quarter decrease of 9.34%. The largest institutional shareholder is James Simons, holding a total of 10.90K shares, representing 0.00% of shares outstanding, with 4.00% increase in holdings.
The current risk assessment score of Beyondspring Inc is 2.11. The company's beta value is 0.45. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.